RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hofseth Biocare A Stock

Hofseth Biocare A Equity 2024

Hofseth Biocare A Equity

41.83 M NOK

Ticker

HBC.OL

ISIN

NO0010598683

WKN

A1JWL4

In 2024, Hofseth Biocare A's equity was 41.83 M NOK, a -71.87% increase from the 148.72 M NOK equity in the previous year.

Hofseth Biocare A Aktienanalyse

What does Hofseth Biocare A do?

Hofseth Biocare A ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Hofseth Biocare A's Equity

Hofseth Biocare A's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Hofseth Biocare A's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Hofseth Biocare A's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Hofseth Biocare A's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Hofseth Biocare A’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Hofseth Biocare A stock

What is the equity of Hofseth Biocare A this year?

Hofseth Biocare A has equity of 41.83 M NOK this year.

What was the equity of Hofseth Biocare A compared to the previous year?

The equity of Hofseth Biocare A has increased/decreased by -71.87% decreased compared to the previous year.

What impact does a high equity have on investors of Hofseth Biocare A?

A high equity is advantageous for investors of Hofseth Biocare A as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Hofseth Biocare A?

A low equity can be a risk for investors of Hofseth Biocare A, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Hofseth Biocare A affect the company?

An increase in equity of Hofseth Biocare A can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Hofseth Biocare A affect the company?

A reduction in equity of Hofseth Biocare A can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Hofseth Biocare A?

Some factors that can affect the equity of Hofseth Biocare A include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Hofseth Biocare A so important for investors?

The equity of Hofseth Biocare A is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Hofseth Biocare A take to change the equity?

To change equity, Hofseth Biocare A can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Hofseth Biocare A pay?

Over the past 12 months, Hofseth Biocare A paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hofseth Biocare A is expected to pay a dividend of 0 NOK.

What is the dividend yield of Hofseth Biocare A?

The current dividend yield of Hofseth Biocare A is .

When does Hofseth Biocare A pay dividends?

Hofseth Biocare A pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hofseth Biocare A?

Hofseth Biocare A paid dividends every year for the past 0 years.

What is the dividend of Hofseth Biocare A?

For the upcoming 12 months, dividends amounting to 0 NOK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hofseth Biocare A located?

Hofseth Biocare A is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hofseth Biocare A kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hofseth Biocare A from 9/7/2024 amounting to 0 NOK, you needed to have the stock in your portfolio before the ex-date on 9/7/2024.

When did Hofseth Biocare A pay the last dividend?

The last dividend was paid out on 9/7/2024.

What was the dividend of Hofseth Biocare A in the year 2023?

In the year 2023, Hofseth Biocare A distributed 0 NOK as dividends.

In which currency does Hofseth Biocare A pay out the dividend?

The dividends of Hofseth Biocare A are distributed in NOK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hofseth Biocare A

Our stock analysis for Hofseth Biocare A Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hofseth Biocare A Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.